Takara Bio Inc. (TYO:4974)

Takara Bio Balance Sheet

Financials in millions JPY. Fiscal year is April - March.

Assets

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Cash & Equivalents	18,214	29,549	35,416	51,847	23,633
Short-Term Investments	2,237	-	-	-	-
Cash & Short-Term Investments	20,451	29,549	35,416	51,847	23,633
Cash Growth	-30.79%	-16.57%	-31.69%	119.38%	-9.08%
Accounts Receivable	9,903	14,017	11,285	12,448	17,804
Other Receivables	904	-	-	-	-
Receivables	10,807	14,017	11,285	12,448	17,804
Inventory	11,620	12,439	11,850	11,087	24,065
Other Current Assets	2,000	1,674	4,208	2,187	2,639
Total Current Assets	44,878	57,679	62,759	77,569	68,141
Property, Plant & Equipment	62,743	56,954	49,075	40,956	36,395
Long-Term Investments	-	1,727	556	560	476
Goodwill	12,432	6,516	6,488	6,674	6,309
Other Intangible Assets	12,368	1,455	1,539	2,373	2,850
Long-Term Deferred Tax Assets	265	1,003	833	1,067	1,539
Other Long-Term Assets	972	-	2	3	2
Total Assets	133,658	125,334	121,252	129,202	115,712

Liabilities

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Accounts Payable	1,449	1,652	1,543	2,323	1,959
Accrued Expenses	-	1,003	962	1,065	923
Current Portion of Leases	207	193	180	151	137
Current Income Taxes Payable	162	1,984	2,047	5,077	9,941
Other Current Liabilities	5,968	2,299	2,436	5,759	4,420
Total Current Liabilities	7,786	7,131	7,168	14,375	17,380
Long-Term Debt	10,000	-	-	-	-
Long-Term Leases	776	908	788	821	910
Pension & Post-Retirement Benefits	1,027	989	1,102	992	788
Long-Term Deferred Tax Liabilities	1,463	-	-	179	198
Other Long-Term Liabilities	8,639	459	411	382	373
Total Liabilities	29,691	9,487	9,469	16,749	19,649

Shareholders' Equity

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Common Stock	14,965	14,965	14,965	14,965	14,965
Additional Paid-In Capital	32,893	32,893	32,893	32,893	32,893
Retained Earnings	40,819	52,465	53,471	57,047	45,009
Comprehensive Income & Other	14,988	15,176	10,175	7,313	3,005
Total Common Equity	103,665	115,499	111,504	112,218	95,872
Minority Interest	302	348	279	235	191
Shareholders' Equity	103,967	115,847	111,783	112,453	96,063
Total Liabilities & Equity	133,658	125,334	121,252	129,202	115,712

Additional Metrics

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Total Debt	10,983	1,101	968	972	1,047
Net Cash (Debt)	9,468	28,448	34,448	50,875	22,586
Net Cash Growth	-66.72%	-17.42%	-32.29%	125.25%	-9.12%
Net Cash Per Share	78.63	236.25	286.08	422.50	187.57
Filing Date Shares Outstanding	120.42	120.42	120.42	120.42	120.42
Total Common Shares Outstanding	120.42	120.42	120.42	120.42	120.42
Working Capital	37,092	50,548	55,591	63,194	50,761
Book Value Per Share	860.90	959.17	925.99	931.92	796.18
Tangible Book Value	78,865	107,528	103,477	103,171	86,713
Tangible Book Value Per Share	654.94	892.97	859.33	856.79	720.11
Land	9,213	-	-	-	-
Buildings	30,761	-	-	-	-
Machinery	21,290	-	-	-	-
Construction In Progress	27,051	-	-	-	-

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jun 13, 2026

Data Sources Report a data error